Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05123742 · ClinicalTrials.gov registry record
PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice
A clinical trial of COVID-19 Infection, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 72
- Enrollment target
- 1
- Study location
NCT05123742 is a study of COVID-19 Infection that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 72 participants, below the 3,148-participant average among 21 other COVID-19 Infection trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05123742, a study of COVID-19 Infection, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team will conduct a feasibility study to develop and test out procedures for improved triage and COVID-19 testing in dental practices to increase safety and perceptions of the safety of Dental Health Care Workers (DHCW) and their patients. DHCWs in offices with Practice-Based Regional Network (PBRN) members and their patients will be recruited to participate in one of two protocols. The first, point-of-care (POC), will test out procedures for point-of-care SARS-CoV-2 antigen testing in the dental office along with enhanced triage using pulse oximeters. The second, laboratory (LAB), will test out procedures for a saliva-based laboratory SARS-CoV-2 viral test along with enhanced triage. The feasibility of implementing COVID-related testing and enhanced triage procedures in the dental setting will provide preliminary data to inform a larger network-wide study grant application.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST COVID-19 Testing
Study Locations (1)
New Jersey
- Rutgers School of Dental Medicine - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-12-13 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05123742
The ClinicalTrials.gov registry entry for NCT05123742 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,148-participant average among 21 other COVID-19 Infection trials with a reported enrollment target (98% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COVID-19 Infection appearing as the primary indexed condition, and to 1 intervention - of which COVID-19 Testing is the first listed.
NCT05123742 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT05123742 about?
NCT05123742 is a clinical study titled "PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice". The study team will conduct a feasibility study to develop and test out procedures for improved triage and COVID-19 testing in dental practices to increase safety and perceptions of the safety of Dental Health Care Workers (DHCW) and their patients. DHCWs in offices with Practice-Based Regional Netw...
What is the current status of trial NCT05123742?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2021-12-13. Estimated completion is 2022-12-31.
What conditions does trial NCT05123742 study?
This clinical trial studies the following conditions: COVID-19 Infection.
What interventions are being tested in trial NCT05123742?
The interventions under investigation include: COVID-19 Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05123742?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05123742 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19 Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
RECRUITING
-
Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
RECRUITING
-
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
RECRUITING · Phase 2
-
The Impact of COVID-19 on Pulmonary Procedures
RECRUITING
-
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
RECRUITING
-
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.